Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab
Key Clinical Message A severe and persistent migrainous headache in a patient with primary Sjøgren's syndrome unresponsive to treatment with immunosuppressive drugs, triptans, opioids, and NSAIDs, responded successfully to intrathecal B‐cell depletion with rituximab. We hypothesize that brain‐r...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.1987 |
id |
doaj-ee44d368d5244938b13ac0f45ff4f4a9 |
---|---|
record_format |
Article |
spelling |
doaj-ee44d368d5244938b13ac0f45ff4f4a92020-11-25T00:45:39ZengWileyClinical Case Reports2050-09042019-03-017341641810.1002/ccr3.1987Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximabAnne Bolette Tjensvoll0Maria Boge Lauvsnes1Katrine Brekke Norheim2Roald Omdal3Department of Neurology Stavanger University Hospital Stavanger NorwayDepartment of Internal Medicine Stavanger University Hospital Stavanger NorwayDepartment of Internal Medicine Stavanger University Hospital Stavanger NorwayDepartment of Internal Medicine Stavanger University Hospital Stavanger NorwayKey Clinical Message A severe and persistent migrainous headache in a patient with primary Sjøgren's syndrome unresponsive to treatment with immunosuppressive drugs, triptans, opioids, and NSAIDs, responded successfully to intrathecal B‐cell depletion with rituximab. We hypothesize that brain‐resident autoreactive B cells were involved in headache pathogenesis and were eliminated by this procedure.https://doi.org/10.1002/ccr3.1987B cell depletion in CSFHeadachePrimary Sjögren’s syndromeSystemic lupus erythematosus |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anne Bolette Tjensvoll Maria Boge Lauvsnes Katrine Brekke Norheim Roald Omdal |
spellingShingle |
Anne Bolette Tjensvoll Maria Boge Lauvsnes Katrine Brekke Norheim Roald Omdal Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab Clinical Case Reports B cell depletion in CSF Headache Primary Sjögren’s syndrome Systemic lupus erythematosus |
author_facet |
Anne Bolette Tjensvoll Maria Boge Lauvsnes Katrine Brekke Norheim Roald Omdal |
author_sort |
Anne Bolette Tjensvoll |
title |
Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab |
title_short |
Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab |
title_full |
Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab |
title_fullStr |
Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab |
title_full_unstemmed |
Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab |
title_sort |
severe headache in primary sjögren’s syndrome treated with intrathecal rituximab |
publisher |
Wiley |
series |
Clinical Case Reports |
issn |
2050-0904 |
publishDate |
2019-03-01 |
description |
Key Clinical Message A severe and persistent migrainous headache in a patient with primary Sjøgren's syndrome unresponsive to treatment with immunosuppressive drugs, triptans, opioids, and NSAIDs, responded successfully to intrathecal B‐cell depletion with rituximab. We hypothesize that brain‐resident autoreactive B cells were involved in headache pathogenesis and were eliminated by this procedure. |
topic |
B cell depletion in CSF Headache Primary Sjögren’s syndrome Systemic lupus erythematosus |
url |
https://doi.org/10.1002/ccr3.1987 |
work_keys_str_mv |
AT annebolettetjensvoll severeheadacheinprimarysjogrenssyndrometreatedwithintrathecalrituximab AT mariabogelauvsnes severeheadacheinprimarysjogrenssyndrometreatedwithintrathecalrituximab AT katrinebrekkenorheim severeheadacheinprimarysjogrenssyndrometreatedwithintrathecalrituximab AT roaldomdal severeheadacheinprimarysjogrenssyndrometreatedwithintrathecalrituximab |
_version_ |
1725268919824941056 |